XML 13 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating expenses:        
Total operating expenses $ 893,792 $ 8,600 $ 1,918,208 $ 33,056
Loss from operations (893,792) (8,600) (1,918,208) 33,056
Interest expense (515,377) (3,635) (1,134,529) 10,698
Net loss and comprehensive loss $ (1,409,169) $ (12,235) $ (3,052,737) $ 43,754
Net loss per share:        
Basic and diluted $ (0.18) $ (0.01) $ (0.41) $ (0.03)
Number of shares used in per share calculations:        
Basic and diluted 7,864,994 1,658,051 7,369,457 1,658,051
NeuroOne LLC        
Operating expenses:        
General and administrative   $ 1,941   $ 6,009
Research and development   0   0
Total operating expenses   1,941   6,009
Loss from operations   (1,941)   (6,009)
Interest expense   (3,635)   (10,698)
Net loss and comprehensive loss   $ (5,576)   $ (16,707)
NeuroOne, Inc. [Member]        
Operating expenses:        
General and administrative $ 622,141   $ 1,798,131  
Research and development 271,651   500,408  
Total operating expenses 893,792   2,298,539  
Loss from operations (893,792)   (2,298,539)  
Interest expense (515,377)   (1,134,529)  
Net loss and comprehensive loss $ (1,409,169)   $ (3,433,068)  
Net loss per share:        
Basic and diluted $ (0.19)   $ (0.55)  
Number of shares used in per share calculations:        
Basic and diluted 7,540,135   6,217,076